AgomAb Therapeutics NV ADR (AGMB)

NASD · Healthcare · Biotechnology · Belgium

AgomAb Therapeutics NV ADR is a micro cap company (market value under $300 million) in the Biotechnology industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the AgomAb Therapeutics NV ADR stock.

Our verdict on AGMB

Not valued: We cannot value this company yet.

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than AGMB in Biotechnology

129 more in this industry show a wider margin of safety.

Is AGMB undervalued or overvalued?

We do not publish a verdict on AGMB yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of AGMB?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.